Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostate cancer detection with [<sup>99m</sup>Tc]Tc-HYNIC-iPSMA SPECT: The Australian experience.

Radiography (London, England : 1995)·2025
Same author

Proton vs photon: A model-based approach to patient selection for reduction of cardiac toxicity in locally advanced lung cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2019
Same author

International Variation in Criteria for Internal Mammary Chain Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Extreme under-reporting of body weight by young adults with obesity: relation to social desirability.

Obesity science & practice·2018
Same author

Addressing vectorborne diseases.

The Veterinary record·2016
Same author

Spatial distribution of Auger electrons emitted from internalised radionuclides in cancer cells: the photoresist autoradiography (PAR) method.

Radiation protection dosimetry·2015

Related Experiment Video

Updated: Oct 19, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K

Combining External Beam Radiation and Radionuclide Therapies: Rationale, Radiobiology, Results and Roadblocks.

E M Abbott1, N Falzone2, N Lenzo3

  • 1MIM Software Inc., Cleveland, Ohio, USA.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|September 21, 2021
PubMed
Summary

Molecular radiotherapy (MRT) is expanding rapidly, with new trials exploring combinations with other cancer drugs and external beam radiotherapy (EBRT). Innovations in imaging and dosimetry will enable combined MRT and EBRT treatments.

Keywords:
Combinationdosimetryexternal beam radiotherapymolecular radiotherapy

More Related Videos

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.7K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K

Related Experiment Videos

Last Updated: Oct 19, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.4K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

9.7K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K

Area of Science:

  • Oncology
  • Radiotherapy
  • Nuclear Medicine

Background:

  • The last decade has seen significant advancements in molecular radiotherapy (MRT) with agents like radium-223 dichloride, [177Lu]Lu-DOTA-TATE, and [177Lu]Lu-PSMA ligands.
  • Ongoing clinical trials are crucial for optimizing MRT dosing and patient selection.
  • Research is exploring combinations of MRT with chemotherapy, DNA repair inhibitors, and immunotherapeutics.

Purpose of the Study:

  • To review the potential of combining molecular radiotherapy (MRT) with external beam radiotherapy (EBRT).
  • To highlight the challenges and opportunities in integrating these two radiotherapeutic modalities.
  • To emphasize the need for further radiobiological research in radionuclide therapy.

Main Methods:

  • Review of current literature on molecular radiotherapy (MRT) and external beam radiotherapy (EBRT).
  • Discussion of technical and dosimetric challenges in combining MRT and EBRT.
  • Identification of innovations facilitating combined treatment approaches.

Main Results:

  • The combination of MRT and EBRT presents a promising avenue for cancer treatment.
  • Past progress has been hindered by technical and dosimetric challenges.
  • Advancements in imaging, MRT dosimetry, and EBRT hardware are paving the way for future integration.

Conclusions:

  • Combining MRT and EBRT holds significant potential for enhanced cancer therapy.
  • Addressing radiobiological research gaps for radionuclide therapy is essential.
  • Technological innovations are critical for the successful implementation of combined MRT and EBRT.